Association between symptom dimensions and categorical diagnoses of psychosis: A cross-sectional and longitudinal investigation

Schizophrenia Bulletin

Volumn 40, Issue 1, 2014, Pages 111-119

  Russo, Manuela ^a,b   Levine, Stephen Z ^c   Demjaha, Arsime ^a   Di Forti, Marta ^a   Bonaccorso, Stefania ^a   Fearon, Paul ^a   Dazzan, Paola ^a   Pariante, Carmine M ^a   David, Anthony S ^a   Morgan, Craig ^a   Murray, Robin M ^a   Reichenberg, Abraham ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

diagnostic classification; DSM 5; longitudinal study; psychosis; symptom dimensions

Indexed keywords

AFFECTIVE PSYCHOSIS; ARTICLE; DELUSION; DEPRESSION; DEPRESSIVE PSYCHOSIS; DISORIENTATION; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; PSYCHOSIS;

DIAGNOSTIC CLASSIFICATION; DSM-5; LONGITUDINAL STUDY; PSYCHOSIS; SYMPTOM DIMENSIONS;

ADOLESCENT; ADULT; AGED; BEHAVIORAL SYMPTOMS; CROSS-SECTIONAL STUDIES; FACTOR ANALYSIS, STATISTICAL; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84892651367     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt055     Document Type: Article

References (40)

1. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry. 2006;11:815-836.
2. Joyce EM, Hutton SB, Mutsatsa SH, Barnes TR. Cognitive heterogeneity in first-episode schizophrenia. Br J Psychiatry. 2005;187:516-522.
3. Stroup TS. Heterogeneity of treatment effects in schizophrenia. Am J Med. 2007;120:S26-S31.
4. Post RM. Comparative pharmacology of bipolar disorder and schizophrenia. Schizophr Res. 1999;39:153-8.
5. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res. 2004;71:405-416.
6. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull. 2006;32:9-16.
7. McDonald C, Bullmore E, Sham P, et al. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry. 2005;186:369-377.
8. Allardyce J, McCreadie RG, Morrison G, van Os J. Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Soc Psychiatry Psychiatr Epidemiol. 2007;42:429-437.
9. van Os J, Tamminga C. Deconstructing psychosis. Schizophr Bull. 2007;33:861-862.
10. Van Os J, Gilvarry C, Bale R, et al. A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychol Med. 1999;29:595-606.
11. Demjaha A, Morgan K, Morgan C, et al. Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11? Psychol Med. 2009;39:1943-1955.
12. Blashfield RK. The classification of psychopathology: Neo-Kraepelinian and quantitative approaches. Plenum, New York; 1984.
13. Foulds GA, Bedford A. Hierarchy of classes of personal illness. Psychol Med. 1975;5:181-192.
14. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
15. Regier DA. Dimensional approaches to psychiatric classification: refining the research agenda for DSM-V: an introduction. Int J Methods Psychiatr Res. 2007;16 Suppl 1:S1-S5.
16. van Os J, Kapur S. Schizophrenia. Lancet. 2009;374:635-645.
17. Crow TJ. Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry. 1980;137:383-386.
18. Liddle PF. The symptoms of chronic schizophrenia. A reexamination of the positive-negative dichotomy. Br J Psychiatry. 1987;151:145-151.
19. Andreasen NC, Olsen S. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry. 1982;39: 789-794.
20. McGorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med. 1998;28:935-947.
21. Lindenmayer JP, Bossie CA, Kujawa M, Zhu Y, Canuso CM. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale. Psychopathology. 2008;41:264-270.
22. Cuesta MJ, Peralta V. Integrating psychopathological dimensions in functional psychoses: a hierarchical approach. Schizophr Res. 2001;52:215-229.
23. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry. 1995;52:352-360.
24. Maziade M, Bouchard S, Gingras N, et al. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome. Br J Psychiatry. 1996;169:371-378.
25. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry. 1990;47:589-593.
26. Kirkbride JB, Fearon P, Morgan C, et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry. 2006;63:250-258.
27. Mondelli V, Dazzan P, Hepgul N, et al. Abnormal cortisol levels during the day and cortisol awakening response in firstepisode psychosis: the role of stress and of antipsychotic treatment. Schizophr Res. 2010;116:234-242.
28. Gorsuch RL. Factor Analysis. 2nd ed. Hillsdale, NJ: Lea; 1983.
29. Tabachnick BG, Fidell LS, Osterlind SJ. Using Multivariate Statistics. 4th ed. Boston, MA: Allyn and Bacon; 2001.
30. Wolff HG, Preising K. Exploring item and higher order factor structure with the Schmid-Leiman solution: syntax codes for SPSS and SAS. Behav Res Methods. 2005;37:48-58.
31. Loehlin JC. Latent variable models: An introduction to factor, path, and structural analysis. Lawrence, KS: Erlbaum Associates Publishers; 1998.
32. Schreiber JB, Nora A, Stage FK, Barlow EA, King J. Reporting structural equation modeling and confirmatory factor analysis results: A review. J Educ Res. 2006;99:323-338.
33. American Psychiatric Association DSM-5 Development. http://www.dsm5.org/ ProposedRevision/Pages/proposedrevision. aspx?rid=411#. Accessed March 15, 2012.
34. Addington J, Mancuso E. Cognitive-behavioral therapy for individuals at high risk of developing psychosis. J Clin Psychol. 2009;65:879-890.
35. Velligan DI. Cognitive behavior therapy for psychosis: where have we been and where are we going? Schizophr Bull. 2009;35:857-858.
36. Cuesta MJ, Peralta V. Testing the hypothesis that formal thought disorders are severe mood disorders. Schizophr Bull. 2011;37:1136-1146.
37. Guerra A, Fearon P, Sham P, et al. The relationship between predisposing factors, premorbid function and symptom dimensions in psychosis: an integrated approach. Eur Psychiatry. 2002;17:311-320.
38. Raymond Lake C. Disorders of thought are severe mood disorders: the selective attention defect in mania challenges the Kraepelinian dichotomy a review. Schizophr Bull. 2008;34:109-117.
39. Bromet EJ, Kotov R, Fochtmann LJ, et al. Diagnostic shifts during the decade following first admission for psychosis. Am J Psychiatry. 2011;168:1186-1194.
40. Lake CR, Hurwitz N. Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease-there is no schizoaffective disorder. Curr Opin Psychiatry. 2007; 20:365-379.